These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 36596207)

  • 1. Inulin intervention attenuates hepatic steatosis in rats via modulating gut microbiota and maintaining intestinal barrier function.
    Yang Z; Su H; Lv Y; Tao H; Jiang Y; Ni Z; Peng L; Chen X
    Food Res Int; 2023 Jan; 163():112309. PubMed ID: 36596207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota.
    Chen L-p; Zhang L-f; Liu S; Hua H; Zhang L; Liu B-c; Wang R-r
    Microbiol Spectr; 2024 Jun; 12(6):e0197923. PubMed ID: 38647315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier.
    Li Y; Liu T; Yan C; Xie R; Guo Z; Wang S; Zhang Y; Li Z; Wang B; Cao H
    Mol Pharm; 2018 Sep; 15(9):3860-3870. PubMed ID: 30036479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease.
    Chambers ES; Byrne CS; Rugyendo A; Morrison DJ; Preston T; Tedford C; Bell JD; Thomas L; Akbar AN; Riddell NE; Sharma R; Thursz MR; Manousou P; Frost G
    Diabetes Obes Metab; 2019 Feb; 21(2):372-376. PubMed ID: 30098126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inulin supplementation ameliorates hyperuricemia and modulates gut microbiota in Uox-knockout mice.
    Guo Y; Yu Y; Li H; Ding X; Li X; Jing X; Chen J; Liu G; Lin Y; Jiang C; Liu Z; He Y; Li C; Tian Z
    Eur J Nutr; 2021 Jun; 60(4):2217-2230. PubMed ID: 33104864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hericium erinaceus polysaccharides ameliorate nonalcoholic fatty liver disease via gut microbiota and tryptophan metabolism regulation in an aged laying hen model.
    Wu L; Hu Z; Lv Y; Ge C; Luo X; Zhan S; Huang W; Shen X; Yu D; Liu B
    Int J Biol Macromol; 2024 Jul; 273(Pt 1):132735. PubMed ID: 38825293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats.
    Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W
    Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation.
    Gao LL; Ma JM; Fan YN; Zhang YN; Ge R; Tao XJ; Zhang MW; Gao QH; Yang JJ
    Int J Biol Macromol; 2021 Jul; 183():1379-1392. PubMed ID: 33992651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota and butyrate contribute to nonalcoholic fatty liver disease in premenopause due to estrogen deficiency.
    Liu L; Fu Q; Li T; Shao K; Zhu X; Cong Y; Zhao X
    PLoS One; 2022; 17(2):e0262855. PubMed ID: 35108315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Lactalbumin peptide Asp-Gln-Trp alleviates hepatic insulin resistance and modulates gut microbiota dysbiosis in high-fat diet-induced NAFLD mice.
    Chen H; Sun Y; Zhao H; Qi X; Cui H; Li Q; Ma Y
    Food Funct; 2022 Oct; 13(19):9878-9892. PubMed ID: 36052713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prebiotic Inulin and Sodium Butyrate Attenuate Obesity-Induced Intestinal Barrier Dysfunction by Induction of Antimicrobial Peptides.
    Beisner J; Filipe Rosa L; Kaden-Volynets V; Stolzer I; Günther C; Bischoff SC
    Front Immunol; 2021; 12():678360. PubMed ID: 34177920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen inhalation ameliorates hepatic inflammation and modulates gut microbiota in rats with high-fat diet-induced non-alcoholic fatty liver disease.
    Xue J; Zhao M; Liu Y; Jia X; Zhang X; Gu Q; Xie Y; Qin S; Liu B
    Eur J Pharmacol; 2023 May; 947():175698. PubMed ID: 36997047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inulin Improves Diet-Induced Hepatic Steatosis and Increases Intestinal
    Pérez-Monter C; Álvarez-Arce A; Nuño-Lambarri N; Escalona-Nández I; Juárez-Hernández E; Chávez-Tapia NC; Uribe M; Barbero-Becerra VJ
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The modulation of Luffa cylindrica (L.) Roem supplementation on gene expression and amino acid profiles in liver for alleviating hepatic steatosis via gut microbiota in high-fat diet-fed mice: insight from hepatic transcriptome analysis.
    Zhang L; Wang P; Shi M; Fang Z; Ji J; Liao X; Hu X; Chen F
    J Nutr Biochem; 2020 Jun; 80():108365. PubMed ID: 32217466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
    Wang W; Zhao J; Gui W; Sun D; Dai H; Xiao L; Chu H; Du F; Zhu Q; Schnabl B; Huang K; Yang L; Hou X
    Br J Pharmacol; 2018 Feb; 175(3):469-484. PubMed ID: 29139555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoprotective effect of curcumin against bisphenol A-induced hepatic steatosis via modulating gut microbiota dysbiosis and related gut-liver axis activation in CD-1 mice.
    Hong T; Jiang X; Zou J; Yang J; Zhang H; Mai H; Ling W; Feng D
    J Nutr Biochem; 2022 Nov; 109():109103. PubMed ID: 35780999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prebiotic inulin as a treatment of obesity related nonalcoholic fatty liver disease through gut microbiota: a critical review.
    Hu Y; He J; Zheng P; Mao X; Huang Z; Yan H; Luo Y; Yu J; Luo J; Yu B; Chen D
    Crit Rev Food Sci Nutr; 2023; 63(7):862-872. PubMed ID: 34292103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Strains of
    Hu W; Gao W; Liu Z; Fang Z; Wang H; Zhao J; Zhang H; Lu W; Chen W
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.